Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-25 @ 5:05 PM
NCT ID: NCT04168203
Description: Definitions do not differ
Frequency Threshold: 0
Time Frame: 1 year
Study: NCT04168203
Study Brief: Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Extended Duration Thromboprophylaxis apixaban 2.5 mg orally twice daily for a duration of 12 months Apixaban 2.5 MG: apixaban 2.5 mg orally twice daily for a duration of 12 months 1 None 0 300 6 300 View
Control oral placebo for a duration of 12 months Placebo oral tablet: placebo oral tables twice daily for a duration of 12 months 3 None 0 300 6 300 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Adverse Drug Reactions SYSTEMATIC_ASSESSMENT General disorders None View